These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 6219974

  • 1. Lung vessel leak precedes right ventricular hypertrophy in monocrotaline-treated rats.
    Sugita T, Hyers TM, Dauber IM, Wagner WW, McMurtry IF, Reeves JT.
    J Appl Physiol Respir Environ Exerc Physiol; 1983 Feb; 54(2):371-4. PubMed ID: 6219974
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin converting enzyme activity and evolution of pulmonary vascular disease in rats with monocrotaline pulmonary hypertension.
    Kay JM, Keane PM, Suyama KL, Gauthier D.
    Thorax; 1982 Feb; 37(2):88-96. PubMed ID: 6281933
    [Abstract] [Full Text] [Related]

  • 3. Dose-response relationship in intoxication by the pyrrolizidine alkaloid monocrotaline.
    Shubat PJ, Hubbard AK, Huxtable RJ.
    J Toxicol Environ Health; 1989 Feb; 28(4):445-60. PubMed ID: 2531804
    [Abstract] [Full Text] [Related]

  • 4. Pulmonary toxicity of monocrotaline differs at critical periods of lung development.
    Todd L, Mullen M, Olley PM, Rabinovitch M.
    Pediatr Res; 1985 Jul; 19(7):731-7. PubMed ID: 3161000
    [Abstract] [Full Text] [Related]

  • 5. Supplemental oxygen reduces right ventricular hypertrophy in monocrotaline-injected rats.
    Hill NS, Jederlinic P, Gagnon J.
    J Appl Physiol (1985); 1989 Apr; 66(4):1642-8. PubMed ID: 2525121
    [Abstract] [Full Text] [Related]

  • 6. Development of morphologic, hemodynamic, and biochemical changes in lungs of rats given monocrotaline pyrrole.
    Reindel JF, Ganey PE, Wagner JG, Slocombe RF, Roth RA.
    Toxicol Appl Pharmacol; 1990 Nov; 106(2):179-200. PubMed ID: 2256110
    [Abstract] [Full Text] [Related]

  • 7. Chemical sympathectomy and serotonin inhibition reduce monocrotaline-induced right ventricular hypertrophy in rats.
    Tucker A, Bryant SE, Frost HH, Migally N.
    Can J Physiol Pharmacol; 1983 Apr; 61(4):356-62. PubMed ID: 6222785
    [Abstract] [Full Text] [Related]

  • 8. PAF antagonists inhibit monocrotaline-induced lung injury and pulmonary hypertension.
    Ono S, Voelkel NF.
    J Appl Physiol (1985); 1991 Dec; 71(6):2483-92. PubMed ID: 1838107
    [Abstract] [Full Text] [Related]

  • 9. Effect of monocrotaline ingestion on the distribution of protein and angiotensin converting enzyme activity in the rat lung.
    Shale DJ, Wiseman MS, Cookson WO.
    Thorax; 1986 Dec; 41(12):914-8. PubMed ID: 3035737
    [Abstract] [Full Text] [Related]

  • 10. Ventilatory dysfunction precedes pulmonary vascular changes in monocrotaline-treated rats.
    Lai YL, Olson JW, Gillespie MN.
    J Appl Physiol (1985); 1991 Feb; 70(2):561-6. PubMed ID: 1902454
    [Abstract] [Full Text] [Related]

  • 11. Monocrotaline pyrrole-induced cardiopulmonary toxicity is not altered by metergoline or ketanserin.
    Ganey PE, Sprugel KH, Hadley KB, Roth RA.
    J Pharmacol Exp Ther; 1986 Apr; 237(1):226-31. PubMed ID: 2937908
    [Abstract] [Full Text] [Related]

  • 12. Differentiation of the cardiac and pulmonary toxicity of monocrotaline, a pyrrolizidine alkaloid.
    Lafranconi WM, Duhamel RC, Brendel K, Huxtable RJ.
    Biochem Pharmacol; 1984 Jan 15; 33(2):191-7. PubMed ID: 6200114
    [Abstract] [Full Text] [Related]

  • 13. Effect of methylprednisolone on monocrotaline-induced pulmonary vascular disease and right ventricular hypertrophy.
    Langleben D, Reid LM.
    Lab Invest; 1985 Mar 15; 52(3):298-303. PubMed ID: 3156262
    [Abstract] [Full Text] [Related]

  • 14. An evaluation of procoagulant activity in the peripheral blood of rats treated with monocrotaline pyrrole.
    Schultze AE, Wagner JG, Roth RA.
    Toxicol Appl Pharmacol; 1991 Jul 15; 109(3):421-31. PubMed ID: 1830177
    [Abstract] [Full Text] [Related]

  • 15. Neither anticoagulant nor nonanticoagulant heparin affects monocrotaline lung injury.
    Fasules JW, Stenmark KR, Henson PM, Voelkel NF, Reeves JT.
    J Appl Physiol (1985); 1987 Feb 15; 62(2):816-20. PubMed ID: 3104299
    [Abstract] [Full Text] [Related]

  • 16. Changes in pulmonary structure and function induced by monocrotaline intoxication.
    Ghodsi F, Will JA.
    Am J Physiol; 1981 Feb 15; 240(2):H149-55. PubMed ID: 6451183
    [Abstract] [Full Text] [Related]

  • 17. Monokine-induced lung injury in rats: similarities to monocrotaline-induced pneumotoxicity.
    Gillespie MN, Olson JW, Hennig B, Cohen DA, McClain CJ, Goldblum SE.
    Toxicol Appl Pharmacol; 1989 Mar 15; 98(1):134-43. PubMed ID: 2494779
    [Abstract] [Full Text] [Related]

  • 18. Effects of thrombocytopenia on monocrotaline pyrrole-induced pulmonary hypertension.
    Hilliker KS, Bell TG, Lorimer D, Roth RA.
    Am J Physiol; 1984 Jun 15; 246(6 Pt 2):H747-53. PubMed ID: 6742140
    [Abstract] [Full Text] [Related]

  • 19. Monocrotaline-induced cardiopulmonary injury in rats. Modification by the neutrophil elastase inhibitor SC39026.
    Molteni A, Ward WF, Ts'ao CH, Hinz JM.
    Biochem Pharmacol; 1989 Aug 01; 38(15):2411-9. PubMed ID: 2547380
    [Abstract] [Full Text] [Related]

  • 20. Pulmonary hypertension induced in rats by monocrotaline and chronic hypoxia is reduced by p-chlorophenylalanine.
    Kay JM, Keane PM, Suyama KL.
    Respiration; 1985 Aug 01; 47(1):48-56. PubMed ID: 3156395
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.